DCOYVSGTBP• 3 Months (Normalized)
DCOY vs GTBP (Decoy Therapeutics Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DCOY Performance $1.97
-73.05%
Decoy Therapeutics Inc.
Normalized Baseline0.00%
GTBP Performance $6.88
+%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-73.05 pts
GTBP outperforming by 73.05 percentage points
DCOYGTBP
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DCOY GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | DCOY Price | DCOY Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 30, 2026 | $1.97 | -73.05% | $- | - | |
| Sep 29, 2026 | $2.13 | -70.86% | $6.88 | +1356.57% | -1427.43% |
| Sep 28, 2026 | $2.31 | -68.40% | $6.80 | +1340.68% | -1409.08% |
| Sep 25, 2026 | $3.09 | -57.73% | $6.89 | +1359.75% | -1417.48% |
| Sep 24, 2026 | $3.11 | -57.46% | $6.83 | +1347.03% | -1404.49% |
| Sep 23, 2026 | $3.85 | -47.33% | $7.10 | +1404.24% | -1451.57% |
| Sep 22, 2026 | $3.10 | -57.59% | $- | - | |
| Sep 21, 2026 | $2.56 | -64.98% | $7.18 | +1421.19% | -1486.17% |
| Sep 18, 2026 | $2.78 | -61.97% | $7.16 | +1416.95% | -1478.92% |
| Sep 17, 2026 | $2.83 | -61.29% | $7.49 | +1486.86% | -1548.15% |
| Sep 16, 2026 | $2.89 | -60.47% | $7.81 | +1554.66% | -1615.13% |
| Sep 15, 2026 | $2.71 | -62.93% | $9.00 | +1806.78% | -1869.71% |
| Sep 14, 2026 | $2.71 | -62.93% | $11.63 | +2363.98% | -2426.91% |
| Sep 11, 2026 | $2.67 | -63.47% | $8.61 | +1724.15% | -1787.62% |
| Sep 10, 2026 | $2.73 | -62.65% | $6.18 | +1209.32% | -1271.97% |
Page 1 of 5